DeFi Technologies Acquires Majority Stake in Swiss Artificial Intelligence and Asset Management Firm Neuronomics AG
DeFi Technologies (DEFTF) has increased its stake in Swiss asset management firm Neuronomics AG to 52.5%, up from its previous 10% ownership. Neuronomics specializes in artificial intelligence and computational neuroscience-based trading strategies, holding a FINMA asset management license.
The acquisition strengthens DeFi Technologies' AI and trading capabilities while complementing its DeFi Alpha arbitrage trading desk. Neuronomics' AI-powered quantitative strategy has shown impressive results in forward-testing, with:
- Annual returns of 80%
- Reduced drawdowns and volatility
- Sharpe Ratio greater than 1
- Positive returns during recent 20% market downturn
As part of the acquisition terms, DeFi Technologies issued 186,304 common shares, with 152,433 shares subject to a lock-up period (50% released in three months, remainder in six months). Additional cash considerations were included in the deal.
DeFi Technologies (DEFTF) ha aumentato la sua partecipazione nella società svizzera di gestione patrimoniale Neuronomics AG al 52,5%, rispetto al precedente 10% di proprietà. Neuronomics si specializza in strategie di trading basate sull'intelligenza artificiale e sulla neuroscienza computazionale, detenendo una licenza di gestione patrimoniale della FINMA.
L'acquisizione rafforza le capacità di trading e di intelligenza artificiale di DeFi Technologies, complementando il suo desk di trading arbitrale DeFi Alpha. La strategia quantitativa basata sull'IA di Neuronomics ha mostrato risultati impressionanti nei test futuri, con:
- Ritorni annuali dell'80%
- Riduzione delle perdite e della volatilità
- Sharpe Ratio superiore a 1
- Ritorni positivi durante il recente calo del mercato del 20%
Come parte dei termini di acquisizione, DeFi Technologies ha emesso 186.304 azioni ordinarie, di cui 152.433 soggette a un periodo di lock-up (il 50% rilasciato dopo tre mesi, il resto dopo sei mesi). Sono state incluse ulteriori considerazioni in contante nell'accordo.
DeFi Technologies (DEFTF) ha aumentado su participación en la firma suiza de gestión de activos Neuronomics AG al 52.5%, frente al 10% de propiedad anterior. Neuronomics se especializa en estrategias de trading basadas en inteligencia artificial y neurociencia computacional, y posee una licencia de gestión de activos de la FINMA.
La adquisición fortalece las capacidades de IA y trading de DeFi Technologies, complementando su mesa de trading de arbitraje DeFi Alpha. La estrategia cuantitativa impulsada por IA de Neuronomics ha mostrado resultados impresionantes en pruebas futuras, con:
- Retornos anuales del 80%
- Reducción de pérdidas y volatilidad
- Ratio de Sharpe superior a 1
- Retornos positivos durante la reciente caída del mercado del 20%
Como parte de los términos de la adquisición, DeFi Technologies emitió 186,304 acciones ordinarias, de las cuales 152,433 están sujetas a un período de bloqueo (el 50% se liberará en tres meses, el resto en seis meses). Se incluyeron consideraciones adicionales en efectivo en el acuerdo.
DeFi Technologies (DEFTF)는 스위스 자산 관리 회사 Neuronomics AG의 지분을 10%에서 52.5%로 늘렸습니다. Neuronomics는 인공지능 및 계산 신경과학 기반의 거래 전략을 전문으로 하며, FINMA 자산 관리 라이센스를 보유하고 있습니다.
이번 인수는 DeFi Technologies의 AI 및 거래 능력을 강화하며, DeFi Alpha 차익 거래 데스크를 보완합니다. Neuronomics의 AI 기반 정량 전략은 미래 테스트에서 인상적인 결과를 보여주었으며, 다음과 같은 성과를 기록했습니다:
- 연간 수익률 80%
- 손실 및 변동성 감소
- 샤프 비율 1 이상
- 최근 20% 시장 하락 동안 긍정적인 수익률
인수 조건의 일환으로, DeFi Technologies는 186,304주를 발행했으며, 그 중 152,433주는 잠금 기간에 있습니다 (50%는 3개월 후에 해제, 나머지는 6개월 후에 해제). 거래에는 추가 현금 고려 사항이 포함되었습니다.
DeFi Technologies (DEFTF) a augmenté sa participation dans la société suisse de gestion d'actifs Neuronomics AG à 52,5%, contre 10% auparavant. Neuronomics se spécialise dans les stratégies de trading basées sur l'intelligence artificielle et les neurosciences computationnelles, et détient une licence de gestion d'actifs de la FINMA.
L'acquisition renforce les capacités de trading et d'IA de DeFi Technologies tout en complétant son bureau de trading d'arbitrage DeFi Alpha. La stratégie quantitative alimentée par l'IA de Neuronomics a montré des résultats impressionnants lors des tests futurs, avec:
- Des rendements annuels de 80%
- Une réduction des pertes et de la volatilité
- Un ratio de Sharpe supérieur à 1
- Des rendements positifs lors de la récente baisse de 20% du marché
Dans le cadre des termes de l'acquisition, DeFi Technologies a émis 186 304 actions ordinaires, dont 152 433 sont soumises à une période de blocage (50% libérées dans trois mois, le reste dans six mois). Des considérations monétaires supplémentaires ont été incluses dans l'accord.
DeFi Technologies (DEFTF) hat seinen Anteil an der Schweizer Vermögensverwaltungsgesellschaft Neuronomics AG auf 52,5% erhöht, nachdem er zuvor 10% besaß. Neuronomics spezialisiert sich auf Handelsstrategien, die auf künstlicher Intelligenz und computergestützter Neurowissenschaft basieren, und hält eine FINMA-Vermögensverwaltungslizenz.
Die Übernahme stärkt die KI- und Handelsfähigkeiten von DeFi Technologies und ergänzt den DeFi Alpha Arbitrage-Handelsbereich. Die KI-gesteuerte quantitative Strategie von Neuronomics hat in Vorabtests beeindruckende Ergebnisse gezeigt, mit:
- Jährlichen Renditen von 80%
- Verringerung der Rückgänge und Volatilität
- Sharpe-Ratio über 1
- Positive Renditen während des jüngsten 20%-Marktrückgangs
Im Rahmen der Übernahmebedingungen gab DeFi Technologies 186.304 Stammaktien aus, von denen 152.433 einer Lock-up-Periode unterliegen (50% werden nach drei Monaten freigegeben, der Rest nach sechs Monaten). Weitere Barüberlegungen wurden in den Deal aufgenommen.
- Acquisition provides majority control (52.5%) of a FINMA-licensed asset management firm
- AI strategy shows 80% annual returns in forward-testing
- Demonstrated positive returns during 20% market downturn
- Diversifies revenue streams through AI-powered trading
- Integration with existing DeFi Alpha trading desk enhances capabilities
- Share dilution through issuance of 186,304 new common shares
- Additional undisclosed cash consideration required for acquisition
- Forward-testing results not yet proven in real-market conditions
- DeFi Technologies Increases its Stake in Neuronomics AG to
52.5% : DeFi Technologies acquires a majority stake in Neuronomics AG, a Swiss asset management firm specializing in artificial intelligence and computational neurosciences. - Strategic Expansion in Asset Management and Trading: This acquisition strengthens DeFi Technologies' artificial intelligence, asset management and trading capabilities, diversifying revenue streams while complementing DeFi Alpha, the Company's specialized arbitrage trading desk.
- Technological Innovation and Performance Excellence: Neuronomics utilizes advanced model-driven quantitative strategies that have delivered exceptional risk-adjusted performance. By significantly outperforming benchmarks, Neuronomics positions DeFi Technologies for continued growth in the asset management sector and the wider cryptocurrency market.
DeFi Technologies' Previous Investment and Strategic Expansion
This Acquisition follows DeFi Technologies' earlier subscription to a capital increase in Neuronomics, where the Company acquired a
Strategic Acquisition to Expand Capabilities
Neuronomics, founded in
Artificial Intelligence in Finance
Neuronomics has pioneered the application of advanced AI models in financial settings, delivering AI strategies that outperform market index across all key metrics. The firm's proprietary AI models combine multiple algorithms to enhance predictive accuracy and reduce model overfitting. Their approach translates AI model outputs into portfolio allocations, optimizing asset distribution to maximize returns while managing risk. Additionally, Neuronomics is at the forefront of customizing Large Language Models ("LLMs") for predicting asset price developments based on real-time market news. This capability positions Neuronomics to identify emerging investment narratives well ahead of competitors, offering a distinct edge in the market).
Computational Neuroscience in Finance
Neuronomics also explores how human cognitive biases and emotional responses shape financial behavior, uncovering market inefficiencies that traditional strategies often overlook. Through computational neuroscience, Neuronomics models the neuronal processes of traders, identifying predictable market behaviors that result from overreactions or emotional trading. This approach has been particularly successful in the cryptocurrency market, which is highly influenced by emotional decision-making. Since launching their neurofinance-based crypto strategy in July 2020, Neuronomics has consistently delivered high risk-adjusted returns with minimal correlation to traditional markets
Technological Innovation and Performance Excellence
Neuronomics leverages cutting-edge AI technology to offer high risk-adjusted returns in the cryptocurrency market. Their latest developed AI-powered quantitative strategy, set to launch with DeFi Technologies, has demonstrated exceptional performance, with forward-testing analysis showing annual returns of
These strategies are built on a diversified, long-only crypto portfolio, rebalanced based on advanced AI models that identify market inefficiencies such as momentum and reversal opportunities. The AI-driven approach has consistently outperformed benchmarks like the CCi30 index, achieving a Sharpe Ratio greater than 1, underscoring its superior risk-adjusted returns. Their Neurofin strategy underscores this resilience by generating positive net returns amid a market downturn exceeding
Background on Management
- Dr. Lorric Ziegler, Partner, brings a strong background in AI and computational neuroscience, with a PhD from EPFL and experience in machine learning and AI applications at prominent Swiss investment firms. Since joining Neuronomics in 2021, Dr. Ziegler has optimized the firm's IT, asset management, and risk management processes.
- Dr. Michael Kometer, Co-Founder and Board Member, holds a PhD from the University of
Zurich and is an expert in algorithmic trading and emotional decision-making in finance. His research has been widely cited, and his work integrates neuroscience, AI, and finance to develop cutting-edge investment strategies. - Patrick Schuppli, Partner, manages business operations and relationships at Neuronomics. With a Master's in Business and Economics from the University of
Basel , his expertise in commodity trading and blockchain-based projects has been pivotal in driving business growth. - Gilles Ramstein, AI Scientist, specializes in machine learning and data science. His innovative work in automating financial processes and developing AI-driven strategies has significantly enhanced the firm's predictive models.
Executive Comments
Olivier Roussy Newton, Chief Executive Officer of DeFi Technologies, commented: "This acquisition marks a significant milestone for DeFi Technologies, not only enhancing our position in asset management but also expanding our capabilities in quantitative trading. Neuronomics' expertise in AI and computational neuroscience will complement our existing trading operations, particularly through DeFi Alpha. This acquisition is a natural extension of our growth strategy, which focuses on diversifying revenue streams, strengthening our trading desk, and enhancing our technological expertise in both traditional and decentralized finance markets."
Michael Kometer, Co-Founder of Neuronomics, added: "Partnering with DeFi Technologies presents a unique opportunity to scale our operations and further integrate our advanced AI capabilities and model-driven strategies within DeFi Technologies' broader ecosystem. Together, we will continue to drive innovation and deliver exceptional value to our clients, expanding our reach and operational impact."
Acquisition Details
In connection with the Acquisition, the Company issued 186,304 common shares of the Company (the "Payment Shares"), plus additional cash considerations, to the selling shareholders of Neuronomics. 152,433 of the Payment Shares are subject to a lock-up schedule, with
About Neuronomics AG
Neuronomics AG is a Swiss asset management firm specializing in AI-powered quantitative trading strategies. By integrating artificial intelligence, computational neuroscience and quantitative finance, Neuronomics delivers cutting-edge solutions that drive superior risk-adjusted performance in financial markets. For more information please visit https://www.neuronomics.com/
About DeFi Technologies
DeFi Technologies Inc. (CBOE CA: DEFI) (GR: R9B) (OTC: DEFTF) is a financial technology company that pioneers the convergence of traditional capital markets with the world of decentralized finance (DeFi). With a dedicated focus on industry-leading Web3 technologies, DeFi Technologies aims to provide widespread investor access to the future of finance. Backed by an esteemed team of experts with extensive experience in financial markets and digital assets, we are committed to revolutionising the way individuals and institutions interact with the evolving financial ecosystem. Follow DeFi Technologies on Linkedin and Twitter, and for more details, visit https://defi.tech/
About Valour
Valour Inc. and Valour Digital Securities Limited (together, "Valour") issues exchange traded products ("ETPs") that provide retail and institutional investors with simple and secure access to digital assets through their traditional bank accounts. Valour's fully hedged digital asset ETPs feature low to zero management fees and are listed on various European exchanges, banks, and broker platforms. Valour operates as part of the asset management business line of DeFi Technologies Inc.
For more information about Valour, to subscribe, or to receive updates, visit valour.com
Cautionary note regarding forward-looking information:
This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation. Forward-looking information includes, but is not limited to statements regarding the closing of the Acquisition; returns generated by Neuronomics' AI models; the business and growth opportunities of Neuronomics; synergies realized from the Acquisition; ability of DeFi Technologies to utilize Neuronomics' trading strategies; the regulatory environment with respect to the growth and adoption of decentralized finance and digital assets; the pursuit by the Company and its subsidiaries of business opportunities; and the merits or potential returns of any such opportunities. Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company, as the case may be, to be materially different from those expressed or implied by such forward-looking information. Such risks, uncertainties and other factors include, but is not limited to the growth and development of decentralised finance and digital asset sector; rules and regulations with respect to decentralised finance and digital assets; general business, economic, competitive, political and social uncertainties. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. The Company does not undertake to update any forward-looking information, except in accordance with applicable securities laws.
THE CBOE
View original content to download multimedia:https://www.prnewswire.com/news-releases/defi-technologies-acquires-majority-stake-in-swiss-artificial-intelligence-and-asset-management-firm-neuronomics-ag-302395407.html
SOURCE DeFi Technologies Inc.
FAQ
What are the expected returns from Neuronomics' AI-powered trading strategy for DEFTF?
How many shares did DeFi Technologies (DEFTF) issue for the Neuronomics acquisition?
What percentage stake does DEFTF now own in Neuronomics AG?
How has Neuronomics' Neurofin strategy performed in recent market conditions?
What regulatory licenses does Neuronomics hold for asset management?
